GB0208392D0 - Therapeutic compounds - Google Patents

Therapeutic compounds

Info

Publication number
GB0208392D0
GB0208392D0 GBGB0208392.1A GB0208392A GB0208392D0 GB 0208392 D0 GB0208392 D0 GB 0208392D0 GB 0208392 A GB0208392 A GB 0208392A GB 0208392 D0 GB0208392 D0 GB 0208392D0
Authority
GB
United Kingdom
Prior art keywords
therapeutic compounds
therapeutic
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0208392.1A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Organon Pharma UK Ltd
Original Assignee
Merck Sharp and Dohme Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Sharp and Dohme Ltd filed Critical Merck Sharp and Dohme Ltd
Priority to GBGB0208392.1A priority Critical patent/GB0208392D0/en
Publication of GB0208392D0 publication Critical patent/GB0208392D0/en
Priority to AU2003219312A priority patent/AU2003219312A1/en
Priority to PCT/GB2003/001454 priority patent/WO2003087099A1/fr
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/444—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring heteroatom, e.g. amrinone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GBGB0208392.1A 2002-04-11 2002-04-11 Therapeutic compounds Ceased GB0208392D0 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
GBGB0208392.1A GB0208392D0 (en) 2002-04-11 2002-04-11 Therapeutic compounds
AU2003219312A AU2003219312A1 (en) 2002-04-11 2003-04-03 Imidazo-pyridine derivatives as ligands for gaba receptors
PCT/GB2003/001454 WO2003087099A1 (fr) 2002-04-11 2003-04-03 Derives d'imidazo-pyridine tenant lieu de ligands pour les recepteurs gaba

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0208392.1A GB0208392D0 (en) 2002-04-11 2002-04-11 Therapeutic compounds

Publications (1)

Publication Number Publication Date
GB0208392D0 true GB0208392D0 (en) 2002-05-22

Family

ID=9934691

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0208392.1A Ceased GB0208392D0 (en) 2002-04-11 2002-04-11 Therapeutic compounds

Country Status (3)

Country Link
AU (1) AU2003219312A1 (fr)
GB (1) GB0208392D0 (fr)
WO (1) WO2003087099A1 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7442709B2 (en) * 2003-08-21 2008-10-28 Osi Pharmaceuticals, Inc. N3-substituted imidazopyridine c-Kit inhibitors
US20150374705A1 (en) 2012-02-14 2015-12-31 Shanghai Institues for Biological Sciences Substances for treatment or relief of pain
KR20210061338A (ko) 2018-09-13 2021-05-27 사니오나 에이/에스 Gabaa 수용체 리간드

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3150486A1 (de) * 1981-12-19 1983-08-25 Merck Patent Gmbh, 6100 Darmstadt Imidazo(4,5-c)pyridine, diese enthaltende pharmazeutische zubereitungen und verfahren zu ihrer herstellung
DK40192D0 (da) * 1992-03-26 1992-03-26 Neurosearch As Imidazolforbindelser, deres fremstilling og anvendelse
GB9921150D0 (en) * 1999-09-07 1999-11-10 Merck Sharp & Dohme Therapeutic agents

Also Published As

Publication number Publication date
AU2003219312A1 (en) 2003-10-27
WO2003087099A1 (fr) 2003-10-23

Similar Documents

Publication Publication Date Title
AU2003244650A8 (en) Medicinal compounds
GB0225540D0 (en) Medicinal compounds
GB0204719D0 (en) Medicinal compounds
GB0225535D0 (en) Medicinal compounds
GB0220730D0 (en) Medicinal compounds
GB0225030D0 (en) Medicinal compounds
GB0206876D0 (en) Therapeutic agents
GB0209991D0 (en) Therapeutic agents
GB0209995D0 (en) Therapeutic agents
GB0323258D0 (en) Therapeutic compounds
AU2003215150A8 (en) Therapeutic compounds
GB0219660D0 (en) Therapeutic use
GB0208392D0 (en) Therapeutic compounds
GB0208394D0 (en) Therapeutic agents
GB0201509D0 (en) Therapeutic Compounds
GB0219721D0 (en) Therapeutic compounds
GB0200136D0 (en) Therapeutic compounds
GB0200135D0 (en) Therapeutic Compounds
GB0200134D0 (en) Therapeutic compounds
GB0213383D0 (en) Therapeutic conditions
GB0327426D0 (en) Therapeutic compounds
GB0327425D0 (en) Therapeutic compounds
GB0315140D0 (en) Therapeutic compounds
GB0225538D0 (en) Medicinal compounds
GB0215930D0 (en) Medicinal compounds

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)